deal that saw pharmaceutical giant Pfizer sell its infant formula business to Nestlé in a $11.85 billion billion deal this week is another attempt by Nestle to put profit over public health, said a watchgroup group on Monday.

 

Wenonah Hauter, Executive Director of Food & Water Watch, stated that Nestle's "renewed focus on growing the market for its infant formula products is troubling given the corporation’s track record of using dubious practices to market infant formula in developing countries, where it is often prepared in unhygienic conditions with unsafe water. It appears this investment will pave the way for more dubious marketing practices, which as recently as last year have been criticized by public health groups in Laos."